Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • Photogen to Focus on Cardiovascular Imaging
Aug 2002
NEW HOPE, Pa., Aug. 13 -- Photogen Technologies Inc. announced it will use $16.25 million in new equity capital to implement its restructuring plan, which will focus the company's resources on cardiovascular imaging and lymphography.

Photogen has agreed to split off its photodynamic therapy and laser device business to five founding shareholders in exchange for all their common stock, which represents 52.9 percent of the company's outstanding shares. Photogen will focus its resources on developing PH-50, a cardiovascular imaging agent designed to improve images of the heart and vasculature obtained with computed tomography (CT) machines and N-1177 for use in lymphography.

The company has also signed a financing agreement to sell $16.25 million of common stock to a group of venture capital funds led by Mi3 LP of Wellesley, Mass., and including Oxford Biosciences and New England Partners.

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.